Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Global Vaccine Campaign Gains Pace As Brazil Approves Astra Jab

Mon, 18th Jan 2021 05:34

(Alliance News) - The global Covid-19 vaccination drive gained pace Sunday as Brazil gave its first injections and India pushed on with its massive campaign, while European authorities sought to allay concerns about delays in supplies. 

Brazil's health regulator gave the green light for the Oxford-AstraZeneca PLC vaccine and China's CoronaVac to be used as the Latin American giant suffers a devastating second wave of the coronavirus.

Monica Calazans, a 54-year-old intensive care nurse in Sao Paulo became the first person in Brazil to receive the Chinese CoronaVac jab after the Anvisa watchdog's highly anticipated ruling.

Growing concerns over different strains of the virus have meanwhile prompted governments to tighten curbs in a bid to stem a global death toll that has already surpassed two million. 

India's vaccination drive got off to a successful start on Saturday with more than 224,000 people receiving their first jabs and just three people hospitalized after side effects, the health ministry said Sunday.

The government plans to immunise some 300 million people out of its population of 1.3 billion by July – equivalent to almost the entire US population.

In Europe, both France and Russia were gearing up for a key week in the vaccine effort. 

Russia starts mass immunisations on Monday using its home-grown Sputnik V vaccine, while the French government is hoping to overcome fierce criticism of a sluggish rollout as it begins inoculating the over-75s. 

Across the EU there have been concerns that delays in the delivery of the Pfizer Inc-BioNTech SE vaccine could further slow a campaign which critics have condemned as less agile than in the US or Britain, a recently-departed EU member.

US drugmaker Pfizer said it was working to "significantly" scale up production at its plant in Belgium in the second quarter.

After a short delay, deliveries should be back to the original schedule to the EU from January 25. 

"There's a dip," France's Europe minister Clement Beaune told Franceinfo radio.

"But it's better that it happens now when we have stockpiles than when the wider vaccination campaign starts."

Joe Biden's goal of seeing 100 million vaccine doses injected within his first 100 days in office is meanwhile "absolutely" achievable, top US scientist Anthony Fauci said, days before he is to become the new president's chief advisor on Covid-19.

"The feasibility of his goal is absolutely clear, there's no doubt about it," Fauci told NBC's "Meet the Press".

Biden has unveiled a USD1.9 trillion stimulus plan to revive the economy of the country worst-hit by the virus, which has killed more than 397,000 people in the US.

In Israel, the prison service said it would begin vaccinating all inmates, following an outcry over an announcement from Public Security Minister Amir Ohana that Palestinian prisoners would be the last to get inoculated. 

Israel has given at least one vaccine dose to more than two million of its citizens, a pace widely described as the world's fastest per capita.  

Spain has begun administering second doses to people who had already received the first at the end of December, mostly nursing home residents and care staff.

And in Norway, where 13 frail elderly people died after a first vaccine injection, the Medicines Agency said there was no cause for alarm after suggestions last week that the deaths could be linked to side effects.

"It is quite clear that these vaccines present very little risk, with the minimal exception of the most fragile patients," agency official Steinar Madsen told public broadcaster NRK. 

Until vaccination is widespread, countries across the globe are still having to rely on lockdowns, curfews and social distancing to control the spread of the virus – particularly as new variants proliferate.

On Sunday a Belgian elderly care home said that a British strain of the coronavirus, which several studies suggest is up to 70% more contagious, had been detected in 111 residents and staff. Three residents have died. 

Fears over the strain were cited as the justification for Austria's decision to extend its third national lockdown by another two weeks until February 8.

After months of restrictions resentment is growing in some quarters, with around 100 people arrested Sunday at an anti-lockdown protest in Amsterdam.

Police used water cannon to clear the demonstrators, some of whom threw stones at the officers, Amsterdam city hall said in a statement.

Switzerland and Italy are tightening their restrictions from Monday and Britain will require all arrivals to quarantine and show negative tests. Oman meanwhile said it will close its land borders for up to two weeks.

In the world of sports, Australian Open chief Craig Tiley said the Grand Slam tournament will still begin next month, even as 72 players are now confined to their Melbourne hotel rooms for 14 days after coming into contact with Covid-19 cases on their inbound flights.

source: AFP

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
8 Feb 2024 08:59

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.

Read more
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.